To determine the accuracy of single serum progesterone measurement in the distinction between pregnancy failure and viable intra-uterine pregnancies, and between ectopic pregnancy and all other pregnancies.
Methods of synthesis
How were the studies combined? The sensitivity and specificity were calculated from the published data for each study, separately, and plotted in receiver operating characteristic (ROC) space. In cases where homogeneity could not be rejected, summary estimates of sensitivity and specificity were calculated. Where it was possible to extract data on the performance of a single serum progesterone measurement at more than one threshold from a study, data on different thresholds were used, up to a maximum of four. To control for the increased weight of these studies the number of patients was divided by the number of cut-off points. In the absence of a threshold effect (see below) summary ROC curves were constructed. To correct for bias resulting from the use of multiple 2x2 contingency tables from one study, a summary ROC curve was estimated using a random-effects regression model.
How were differences between studies investigated?
Homogeneity of the studies was tested using a chi-squared test. In case of heterogeneity, logistic regression was used to evaluate if the study characteristics, (i.e. sampling, data collection and study design) were associated with the discriminative capacity of a single serum progesterone measurement; the presence or absence of disease was used as the dependent variable. If one of the study characteristics was found to have a statistically significant impact on the performance of the test, further analysis was performed in subgroups of patients. A Spearman correlation coefficient was calculated for the association between sensitivity and specificity, to explore possible heterogeneity due to a shift in the threshold levels of serum progesterone measurement used to define a positive test. To evaluate whether the accuracy of serum progesterone measurement had changed over time, the diagnostic odds ratio (ratio of true positives to false negatives divided by the ratio of false positives to true negatives) was calculated for each study and plotted against the year of publication. A regression coefficient between the reported diagnostic odds ratio and the year of publication was calculated.
Results of the review
A total of 26 studies were included: 12 prospective cohort studies, 3 prospective case-control studies, 9 retrospective cohort studies and 2 retrospective case-control studies. Sampling of the patients was consecutive in 19 studies; other methods were used in the remaining 8 studies.
Use of single serum progesterone measurement in distinguishing between pregnancy failure and viable intra-uterine pregnancy.
The sensitivity ranged from 0.32 (specificity 0.98) to 1.0 (specificity 0.73), and the specificity from 0.52 (sensitivity 0.92) to 1.0 (sensitivity 0.35 to 0.98). A plot of the studies indicated heterogeneity, which was confirmed by a chisquared test (P<0.001 for both sensitivity and specificity). A logistic regression analysis showed that the performance of the single serum progesterone measurement varied significantly between consecutive and non-consecutive patient series (P=0.003), between prospective and retrospective studies (P=<0.001), and between cohort and case-control studies (P=0.006). A further analysis was limited to the 11 prospective cohort studies in which patients were sampled prospectively. The chi-squared test indicated heterogeneity in the sensitivity and specificity between these studies (P<0.001). The Spearman correlation coefficient was -0.64. Based on this a summary ROC curve was estimated, using only data from prospective cohort studies in which patient sampling was consecutive. This showed that single serum progesterone has almost perfect specificity with a sensitivity of 60%, and can be 95% sensitive with a specificity of 40%. The diagnostic odds ratios did not vary over time (R=0.001, P=0.97).
Use of single serum progesterone measurement in distinguishing between ectopic and non-ectopic pregnancy.
Twenty-two studies reported on this outcome. The sensitivity ranged from 0.17 (specificity 0.79) to 1.0 (specificity 0.28 to 0.60), and the specificity from 0.28 (sensitivity 1.0) to 1.0 (sensitivity 0.71). A plot of the studies indicated heterogeneity, which was confirmed by a chi-squared test (P<0.001 for both sensitivity and specificity). A logistic regression analysis showed that the performance of the single serum progesterone measurement varied significantly between the cohort and case-control studies (P<0.001), but not between prospective and retrospective (P=0.09) and consecutive and non-consecutive studies (P=0.89). A further analysis was limited to cohort studies. The chi-squared test indicated heterogeneity in the sensitivity and specificity between these studies (P<0.001). The Spearman correlation coefficient was -0.66. Based on this a summary ROC curve was estimated, using only data from cohort
